Upload
robert-j-miller-md
View
279
Download
0
Embed Size (px)
Citation preview
Cancer
Robert Miller MDwww.aboutcancer.com
What is Cancer?
“Cancer is a name given to a collection of related diseases, where some of the body’s cells begin to divide without stopping and spread into surrounding tissue.”
www.cancer.gov
What Causes Cancer?
Cancer is a genetic disease—that is, it is caused by changes to genes that control the way our cells function, especially how they grow and divide.
Genetic changes that cause cancer can be inherited from our parents(germ line). They can also arise during a person’s lifetime as a result of errors that occur as cells divide or because of damage to DNA caused by certain environmental exposures (somatic mutations).
Each person’s cancer has a unique combination of genetic changes. As the cancer continues to grow, additional changes will occur.
‘Driver’ MutationsEach cancer is characterized by numerous somatic mutations, of which only a subset contributes to the tumor’s progression.
Scientists want to be able to distinguish these “driver” mutations from the preponderance of neutral “passenger” mutations that characterize each cancer,
Genetic Drivers of CancerThe genetic changes that contribute to cancer
tend to affect three main types of genes:Proto-oncogenes are involved in normal cell growth and division. When these genes are altered they may become cancer-causing genes (or oncogenes), allowing cells to grow and survive when they should not.
Tumor suppressor genes are also involved in controlling cell growth and division. Cells with certain alterations in tumor suppressor genes may divide in an uncontrolled manner.
DNA repair genes are involved in fixing damaged DNA. Cells with mutations in these genes tend to develop additional mutations in other genes. Together, these mutations may cause the cells to become cancerous.
Understanding CancerType: there are more than 100 types of cancer. The cancer is
usually named after the site where it starts and are called carcinoma. There are unusual types like sarcoma, leukemia, myeloma or lymphoma. The biopsy or pathology report will describe the type of cancer and often include multiple other important factors that can effect the prognosis (or outcome).
Stage: how far the cancer has spread. There are generally 4 stages of each type of cancer and currently the AJCC (American Joint Committee on Cancer) 7th edition staging system is used which came out in 2010. The pathology report, the findings from surgery (if done) and imaging studies (e.g. CT scans, MRI scans, PET scans) are all used to try to determine an accurate stage.
Path Report
The diagnosis of cancer usually starts with a biopsy of the tumor (histology) or cancer mass (if possible) or collection of cells (cytology) from the patient. Important things to look for on a pathology report:
1. Type of cancer (where did it start and is it a specific subtype) 2. Invasive or not3. Size and depth of invasion4. Other structures invaded (like lymph nodes or nearby
structures)5. Grade or measure of how mutated or fast growing the cancer
is6. Margins (has it been completely removed)7. Other specific risk or prognostic factors (hormone receptors,
vascular or perineural invasion, proliferation score, ulceration and many other important site specific factors)
8. Genetic profile (e.g. BRACA, ALK, HER2, luminal, Oncotype DX,
EGFR, etc. including NGS or next generation sequencing)
Genetic Profile
Oncotype will determine the risk of a recurrence
Genetic Profile
MammaPrint will determine whether adding chemotherapy (CT) to endocrine therapy (ET) will improved the cure rate
Genetic Profile
Prosigna will classify breast cancer into a molecular category that will have much different risks of recurrence
Using Adjuvant Online to Calculate the Benefit from taking Chemotherapy based on genetic recurrence risk score
Low risk
High risk
Understanding CancerStage: how far the cancer has spread.
There are generally 4 stages of each type of cancer and currently the AJCC (American Joint Committee on Cancer) 7th edition staging system is used which came out in 2010.
The pathology report, the findings from surgery (if done) and imaging studies (e.g. CT scans, MRI scans, PET scans) are all used to try to determine an accurate stage.
Understanding The Stage
AJCC 7th Ed Staging System is based on the TNM SystemT: stand for tumor and cancer be based on size or depth of invasion and commonly goes from T0 to T4N: stands for lymph node spread based on the number of nodes, size of nodes or location of nodes and is usually from N0 to N3M: stands for evidence of distant metastases and is usually M0 or M1
Stage: generally combines all 3 of these (and sometime other factors as well) to group patients into stage categories generally from 0 to 4 but can include sub stages like IVa , IVb or IVc
For breast cancer, the size and number of nodes combine to determine the stage
For colon cancer, the depth of invasion is critical to determine the stage
Understanding The Stage
Why is the stage important?
Because it guides treatment strategies and predicts outcome and survival.
Survival by Stage for Breast Cancer
Years
0III
III
IV
Understanding Treatment Options
Treatments
1.No treatment (either unnecessary, won’t work anyway, it’s not worth it to the patient)
2.Surgery3.Radiation4.Chemotherapy
1.Conventional chemotherapy2.Hormone Therapy3.Immunotherapy4.Targeted Therapy/ Precision
Medicine
Surgery : local treatment, may be disfiguring but if the tumor can be removed it is quite successful
Radiation: regional treatment, may have less side effects then surgery, successful if the cancer is radio-sensitive
Chemotherapy: widespread, treats the whole body, may have significant side effects, success depends completely on whether the cancer is sensitive to the available drugs
Basic Treatments
Combined Modality Therapy in the Treatment of Pediatric
Rhabdomyosarcoma
Treatment 5 Year Survival
Surgery 10 – 20%
Surgery plus PostOp Radiation 40 – 50%
Surgery, Rad. then Chemotherapy 80 – 90%
Precision TherapyPrecision or targeted therapies work by exploiting the molecular underpinnings of cancer. The precision of cancer treatments has become more sophisticated with each passing year.
Therapies that attack multiple genetic drivers of cancer in combination or harness the body’s own immune system to attack tumor cells have improved outcomes for patients with difficult-to-treat cancers.
Of all the newly FDA-approved cancer therapies approved in 2015, 12 (62.5%) are classified as precision therapies.
New Cancer Drugs and Biological FDA Approved in 2015
Best Treatment
How do patients know if they are receiving the best, current available therapy?
Treatment decisions should be made by the patient and family in consultation with a multi disciplinary panel of cancer specialists c/w current NCCN guidelines. These can be accessed free online at NCCN.org or the patient site at www.nccn.org/patients
Treatment decisions should be made by the patient and family in consultation with a multi disciplinary panel of cancer specialists c/w current NCCN guidelines
Should be a Team Approach
www.nccn.org/patients
PrognosisNote that there are many factors that effect the odds and length of survival1.The type and location of the cancer2.The stage and site of spread3.The cancer grade or speed of growth4.Other specific traits of the cancer cell5.The patient’s own health,
age and performance score6.The response to treatment
0 – Asymptomatic (Fully active, able to carry on all pre-disease activities without restriction)1 – Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)2 – Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)3 – Symptomatic, >50% in bed, but not bedbound (Capable of only limited self-care, confined to bed or chair 50% or more of waking hours)4 – Bedbound (Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair)5 – Death
ECOG Performance Score
JOP September 2014 vol. 10no. 5 e335-e341
Survival in Patients with Advanced Cancer Based on
Performance Score
If the patient has a good response to treatment then survival will be prolonged
Survival with Advanced Colon Cancer Based on the Response to
Chemotherapy
Impact of Response to Chemotherapy on Breast Cancer
Patients by Cancer TypeLuminal- A Type Cancers Triple Negative
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
JCO May 20, 2012 vol. 30 no. 15 1796-1804
Recommended Web Sites from Doctor Miller
The best site would be the NCCN / esp. the patient site: www.nccn.org or www.nccn.org/patients
The next best would be from the NCI (National Cancer Institute) or CancerNet at www.cancer.gov the NCI booklets are very good at www.cancer.gov/publications/patient-education
CancerNet from ASCO (American Society of Clinical Oncology) is very good at www.cancer.net
American Cancer Society at www.cancer.org is good
Finally Doctor Miller’s site at www.aboutcancer.com has a large amount of information and a medical video channel